Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review

Date: March 22, 2016
Pages: 63
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I3121E37C56EN
Leaflet:

Download PDF Leaflet

Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review
Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ipsen S.A (Ipsen) is a global specialty biotechnology company. It manufactures and distributes drugs to treat cancer, urological, endocrine and neurological diseases. The company’s flagship products include Decapeptyl for the treatment of prostate cancer; Hexvix for the diagnosis of bladder cancer; Forlax for the symptomatic treatment of constipation in adults and children; Smecta for the symptomatic treatment of acute diarrhea in children and adults, chronic diarrhea and functional bowel pain in adults; Dysport for the treatment of movement disorders, muscle spasticity and in aesthetic medicine and Somatuline for the treatment of acromegaly and neuroendocrine tumors. The company has research and development facilities in Les Ulis, France; Oxford, the UK; and Cambridge, the US. It has a direct presence North America, Europe and Asia-Pacific and markets its products the world over. Ipsen is headquartered in Paris, France.. Ipsen is headquartered in Paris, France.

Ipsen S.A. Key Recent Developments

Feb 16, 2016: Changes to Ipsen Corporate Governance
Oct 29, 2015: Ipsen: sales in the 3rd quarter and first nine months of 2015
Jul 31, 2015: Ipsen: 2015 half-year results
Apr 29, 2015: Ipsen reports strong sales growth in Q1 2015 and raises guidance for the year
Apr 01, 2015: Ipsen inaugurates new Cambridge, MA R&D center, at the heart of the most important biomedical research & innovation hub in the USA, to expand U.S. presence

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Ipsen S.A. - Key Facts
Ipsen S.A. - Key Employees
Ipsen S.A. - Key Employee Biographies
Ipsen S.A. - Major Products and Services
Ipsen S.A. - Pharmaceutical Pipeline Products Data
Ipsen S.A., Pipeline Products by Therapy Area
Ipsen S.A., Pipeline Products by Development Phase
Ipsen S.A. - History
Ipsen S.A. - Company Statement
Ipsen S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Ipsen S.A. - Business Description
Ipsen S.A. - SWOT Analysis
SWOT Analysis - Overview
Ipsen S.A. - Strengths
Strength - Success in International Markets
Strength - Specialty Care Franchise
Strength - Focused Research and Development Activities
Ipsen S.A. - Weaknesses
Weakness - Discontinuation of Studies/ Termination of Trials
Weakness - Patent Infringement Concerns
Ipsen S.A. - Opportunities
Opportunity - Business Initiatives
Opportunity - Growth Prospects: Emerging Markets
Opportunity - Strong Product Pipeline
Ipsen S.A. - Threats
Threat - Dependence on Few Suppliers
Threat - Uncertain R&D Outcomes
Threat - Stringent Government Regulations
Ipsen S.A. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Ipsen S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Ipsen S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Ipsen S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Ipsen S.A., Medical Equipment, Deals By Type, 2010 to YTD 2016
Ipsen S.A., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 16, 2016: Changes to Ipsen Corporate Governance
Oct 29, 2015: Ipsen: sales in the 3rd quarter and first nine months of 2015
Jul 31, 2015: Ipsen: 2015 half-year results
Apr 29, 2015: Ipsen reports strong sales growth in Q1 2015 and raises guidance for the year
Apr 01, 2015: Ipsen inaugurates new Cambridge, MA R&D center, at the heart of the most important biomedical research & innovation hub in the USA, to expand U.S. presence
Apr 01, 2015: Ipsen expands ties to Harvard University with signing of a new Research Alliance Agreement
Mar 03, 2015: Ipsen’s 2014 Results and 2015 Financial Objectives
Mar 02, 2015: Dominique Laymand is Appointed as Ipsen’s Senior Vice President, Chief Ethics and Compliance Officer
Feb 03, 2015: Ipsen: sales in the fourth quarter and full year 2014

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Ipsen S.A., Key Facts
Ipsen S.A., Key Employees
Ipsen S.A., Key Employee Biographies
Ipsen S.A., Major Products and Services
Ipsen S.A., Number of Pipeline Products by Therapy Area
Ipsen S.A., Number of Pipeline Products by Development Stage
Ipsen S.A., Pipeline Products By Therapy Area and Development Phase
Ipsen S.A., History
Ipsen S.A., Subsidiaries
Ipsen S.A., Affiliate
Ipsen S.A., Joint Venture
Ipsen S.A., Key Competitors
Ipsen S.A., Ratios based on current share price
Ipsen S.A., Annual Ratios
Ipsen S.A., Interim Ratios
Ipsen S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Ipsen S.A., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Ipsen S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Ipsen S.A., Medical Equipment, Deals By Type, 2010 to YTD 2016
Ipsen S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Ipsen S.A., Pipeline Products by Therapy Area
Ipsen S.A., Pipeline Products by Development Phase
Ipsen S.A., Performance Chart (2011 - 2015)
Ipsen S.A., Ratio Charts
Ipsen S.A., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Ipsen S.A., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Ipsen S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
Ipsen S.A., Medical Equipment, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: